The authors have shown that long-term treatment of cytomegalovirus (CMV) retinitis with 20-microgram intravitreal injections of cidofovir (HPMPC) is highly effective but may be associated with iritis and profound hypotony. They evaluated the efficacy and safety of 10-microgram intravitreal injections of cidofovir and made comparisons with their findings of 20-microgram injections.status: publishe
OBJECTIVE: To review the pharmacology and pharmacokinetics of intravenous, oral and intraocular ganc...
Cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, HPMPC] is an acyclic nucleoside anal...
The clinical course and the outcome of treatment were studied in 40 patients with primary cytomegalo...
The authors previously conducted a pilot, dose-escalating study which suggested that a 20-micrograms...
In this study we evaluated the safety and efficacy of the nucleoside phosphonate analogue intravitre...
Background: Cytomegalovirus (CMV) retinitis is the most common intraocular infection in patients wit...
To evaluate the decrease in intraocular pressure associated with cidofovir (1-[(S)-3-hydroxy-2-(phos...
The authors characterize and analyze the incidence of a previously reported mild anterior nongranulo...
We report the compassionate use of intravenous cidofovir for the treatment of cytomega-lovirus retin...
Background: Cytomegalovirus (CMV) retinitis is the most common opportunistic ocular infection in AID...
Objective: To report and evaluate intravitreal ganciclovir injections in non-AIDS patients with huma...
Objectives: To evaluate the efficacy, and complications of the high-dose, alternate-week, intravitre...
To determine the visual outcome, progression, and complications of patients with acquired immuno-def...
Objective: We previously reported a long-lasting crystalline lipid pro-drug of cyclic cidofovir, hex...
A 60-year-old male on chemotherapy for multiple myeloma developed cytomegalovirus (CMV) retinitis in...
OBJECTIVE: To review the pharmacology and pharmacokinetics of intravenous, oral and intraocular ganc...
Cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, HPMPC] is an acyclic nucleoside anal...
The clinical course and the outcome of treatment were studied in 40 patients with primary cytomegalo...
The authors previously conducted a pilot, dose-escalating study which suggested that a 20-micrograms...
In this study we evaluated the safety and efficacy of the nucleoside phosphonate analogue intravitre...
Background: Cytomegalovirus (CMV) retinitis is the most common intraocular infection in patients wit...
To evaluate the decrease in intraocular pressure associated with cidofovir (1-[(S)-3-hydroxy-2-(phos...
The authors characterize and analyze the incidence of a previously reported mild anterior nongranulo...
We report the compassionate use of intravenous cidofovir for the treatment of cytomega-lovirus retin...
Background: Cytomegalovirus (CMV) retinitis is the most common opportunistic ocular infection in AID...
Objective: To report and evaluate intravitreal ganciclovir injections in non-AIDS patients with huma...
Objectives: To evaluate the efficacy, and complications of the high-dose, alternate-week, intravitre...
To determine the visual outcome, progression, and complications of patients with acquired immuno-def...
Objective: We previously reported a long-lasting crystalline lipid pro-drug of cyclic cidofovir, hex...
A 60-year-old male on chemotherapy for multiple myeloma developed cytomegalovirus (CMV) retinitis in...
OBJECTIVE: To review the pharmacology and pharmacokinetics of intravenous, oral and intraocular ganc...
Cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, HPMPC] is an acyclic nucleoside anal...
The clinical course and the outcome of treatment were studied in 40 patients with primary cytomegalo...